Overview
Evidence-based recommendations on implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke.
Last reviewed: 2 September 2020
This guidance replaces the NICE medtech innovation briefing on Reveal LINQ insertable cardiac monitor to detect atrial fibrillation after cryptogenic stroke (MIB141).
Diagnostics guidance 41 has been migrated to HealthTech guidance 553.
Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.